Next Generation Gene Therapy Vectors
June 8 - 10, 2021 - KS USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
The inaugural Next Generation Gene Therapy Vectors meeting is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors. Industry pioneers from cutting edge biotechs and world-leading academic vectorology groups including Dyno Therapeutics, 4D Molecular Therapeutics and Generation Bio will share how ever-increasing clinical experience is guiding strategies to decrease the immunogenicity of vectors to allow durable transgene expression, engineer vectors with lower toxicity at higher doses and use innovative technologies to optimise capsid, transgene, and promoter design. Everything in gene therapy starts with the vector, so join this definitive, niche, digital conference to delve into the details of vector design, engineering, and optimization case studies, equipping you with the insights required to deliver transformative therapeutics to patients more effectively and safely than ever before.